New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 4, 2014
08:35 EDTANIPANI Pharmaceuticals reports Q2 EPS (21c), one estimate (13c)
Reports Q2 revenue $6.65M, consensus $7.95M.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
08:48 EDTANIPANI Pharmaceuticals price target raised to $78 from $65 at Roth Capital
Roth Capital hiked its price target on ANI as the firm expects the company's multiple to rise this year ,partially driven by a more diversified product mix and the company's increased cash that it can use to make accretive acquisitions. The firm keeps a Buy rating on the stock.
February 20, 2015
09:14 EDTANIPANI Pharmaceuticals 2015 guidance looks conservative, says Roth Capital
Subscribe for More Information
February 19, 2015
08:41 EDTANIPANI Pharmaceuticals sees FY15 adjusted EPS $2.48-$2.72, consensus $2.67
Subscribe for More Information
08:37 EDTANIPANI Pharmaceuticals reports Q4 adj EPS $1.94, may not compare to consensus 58c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use